Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition)
ISSN: 2444-3824

Gastroenterology and Hepatology is the first journal to cover the latest advances in pathology of the gastrointestinal tract, liver, pancreas, and bile ducts, making it an indispensable tool for gastroenterologists, hepatologists, internists and general practitioners. In addition to the rigorously selected, systematically peer-reviewed manuscripts published in the research sections (Original Articles, Scientific Letters, Editorials, and Letters to the Editor), the journal also contains other important sections, such as Review Articles and Clinical Decision-Making Support, which offer in-depth reviews and updates on issues relating to the specialty.

See more Open Access Option

Indexed in:

SCIE/Journal of Citation Reports, Index Medicus/Medline, Excerpta Medica/EMBASE, SCOPUS, CANCERLIT, IBECS

See more

Follow us:

1.581 (2019)
1.126 (2018)
1.078 (2017)
0.917 (2016)
0.8 (2015)
0.838 (2014)
0.832 (2013)
0.567 (2012)
0.727 (2011)
Impact Factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.

© Clarivate Analytics, Journal Citation Reports 2020

Impact Factor 2019
CiteScore 2019

CiteScore measures average citations received per document published. Read more

CiteScore 2019

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.


SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
Vol. 43. Issue 7.
Pages 349-414 (August - September 2020)
Original article
Bibliometric analysis of the 100 most-cited articles in the field of hepatology
Qiuyu Yu, Shali Tan, Yutang Ren, Manrong He, Xiangsheng Fu, Yan Peng, Xiaowei Tang
Gastroenterol Hepatol. 2020;43:349-57
Scientific letter
Secukinumab-induced ulcerative colitis: Opening Pandora’s box of immunity
Margarita Fernández-de la Varga, Pablo del Pozo-del Valle, Sergio Béjar-Serrano, Alejandro Garrido-Marín, Guillermo Bastida Paz
Gastroenterol Hepatol. 2020;43:358-9
Colonic duplication cyst in adult
Pablo Rodríguez García, Ainhoa Sánchez Pérez, Elena Romera Barba, Purificación Calero García, Rafael González-Costea Martínez
Gastroenterol Hepatol. 2020;43:360-1
Chronography of inflammatory bowel disease
History of inflammatory bowel disease on eleven infographics
Ignacio Marín-Jiménez, Fernando Gomollón
Gastroenterol Hepatol. 2020;43:362
Year 1932: The first detailed description of regional enteritis
Fernando Gomollón, Ignacio Marín-Jiménez
Gastroenterol Hepatol. 2020;43:363-4
Year 1938: First recognition of the perianal disease as part of Crohn's disease
Fernando Gomollón, Ignacio Marín-Jiménez
Gastroenterol Hepatol. 2020;43:365-6
Year 1955: The first clinical trial into inflammatory diseases: Corticosteroids reduce mortality
Fernando Gomollón, Ignacio Marín-Jiménez
Gastroenterol Hepatol. 2020;43:367-8
Year 1977: The active component of sulphasalazine is 5-aminosalycilic acid
Fernando Gomollón, Ignacio Marín-Jiménez
Gastroenterol Hepatol. 2020;43:369-70
Year 1979: Results from the pharmacological treatment of Crohn's disease
Fernando Gomollón, Ignacio Marín-Jiménez
Gastroenterol Hepatol. 2020;43:371-2
Year 1983: Smoking decreases the risk of ulcerative colitis
Ignacio Marín-Jiménez, Fernando Gomollón
Gastroenterol Hepatol. 2020;43:373-4
Year 1990: Predictability of the postoperative course of Crohn's disease
Ignacio Marín-Jiménez, Fernando Gomollón
Gastroenterol Hepatol. 2020;43:375-6
Year 1994: Corticosteroid resistance and dependence among patients with Crohn's disease
Ignacio Marín-Jiménez, Fernando Gomollón
Gastroenterol Hepatol. 2020;43:377-8
Year 2001: Link between susceptibility to Crohn's disease and variations in LRR
Ignacio Marín-Jiménez, Fernando Gomollón
Gastroenterol Hepatol. 2020;43:381-2
Year 2005: Clinical, serological and molecular classification of inflammatory bowel disease
Ignacio Marín-Jiménez, Fernando Gomollón
Gastroenterol Hepatol. 2020;43:383-4
Letter to the editor
COVID-19: A pandemic of values and more
Carlos-A. Mestres
Gastroenterol Hepatol. 2020;43:385-6
Full text access
From the liver ICU to the COVID ICU: The story of a transformation
J. Fernández
Gastroenterol Hepatol. 2020;43:386-8
Full text access
Clinical practice guidelines
AEG-SEED position paper for the resumption of endoscopic activity after the peak phase of the COVID-19 pandemic
José Carlos Marín-Gabriel, Enrique Rodríguez de Santiago
Gastroenterol Hepatol. 2020;43:389-407
Full text access
COVID-19 and inflammatory bowel disease: Questions arising from patient care and follow-up during the initial phase of the pandemic (February–April 2020)
Ignacio Marín-Jiménez, Yamile Zabana, Iago Rodríguez-Lago, Laura Marín, Manuel Barreiro-de Acosta, María Esteve
Gastroenterol Hepatol. 2020;43:408-13
Full text access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.